Tag: High market potential

Browse exclusive Tags!

German company Dynamic42 secures Series A funding to expand globally with their organ-on-chip technology.

Dynamic42 secures mid-seven-figure financing to expand globally and enter the US pharmaceutical market. Their organ-on-chip tech provides better alternatives for drug testing, reducing animal testing and increasing drug safety.

Popular

Subscribe

spot_imgspot_img